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Background/Aims: The androgen dehydroepiandrosterone (DHEA) attenuates allergic inflammatory airway reactions by 
down-regulating the Th2 response in mice. The purpose of this study was to investigate whether DHEA suppresses Th2 
cytokine  production  in  cultured  peripheral  blood  mononuclear  cells  (PBMCs)  from  asthmatic  patients. 
Methods:  Sixty-one  consecutive  suspected  asthmatic  or  non-asthmatic  men u n d e r w e n t  t e s t s  f o r  a s t h m a .  P B M C s  
from each subject were cultured with and without DHEA (0.01～10 μM) for 48 h. The concentrations of interferon (IFN)-
γ,  i nt er l euki n ( I L) - 5, and I L-10 i n t he cul t ure supernat ant  were measured via an enzyme-linked immunosorbent assay. 
Results:  In  PBMCs  from  subjects  exhibiting  methacholine  airway  hyperresponsiveness  (AHR),  DHEA  significantly 
s uppres sed I L- 10,  I L-5,  and I FN- γ product i on i n a dose- dependent manner (all p<0.001) and tended to increase the 
I FN-γ/IL-5 ratio (p=0.087). DHEA (10 μM) suppressed cytokine production to a greater degree in subjects with AHR 
compared  with  those  without  AHR  (IL-5:  24.0±7.8%  vs.  40.9±3.6%,  p<0.01;  IFN-γ:  29.7±7.0%  vs.  54.5±5.1%, 
p<0.01). Cytokine suppression was significantly related to AHR, serum total IgE levels, and skin reactivity to house dust 
mites.
Conclusions: DHEA suppressed both Th1 and Th2 responses, with a Th1 bias, and the degree of suppression was 
associated  with  the  severity  of  AHR  or  atopy.  Therefore,  DHEA  may  be  a  useful  therapy  for  asthma. 
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INTRODUCTION
Asthma  is  associated  with  an  enhanced  Th2  immune 
response
1).  Th1  and  Th2  cells  are  regulated  reciprocally,  and  it 
has  been  shown  that  Th1  enhancers  such  as  bacille  Calmette- 
Guérin  vaccine
2) a n d  C p G  o l i g o d e o x y n u c l e o t i d e s
3)  suppress 
asthmatic  reactions  in  animal  models.  The  adrenal  androgen 
dehydroepiandrosterone (DHEA) is also reported to increase the 
production  of  Th1  cytokines,  including  interleukin  (IL)-2
4, 5) a n d  
interferon  (IFN)-γ
5),  and  to  prevent  or  attenuate  allergic 
inflammatory  airway  responses  in  an  animal  model  of  asthma
6, 7). 
In  a  study  on  human  peripheral  blood  mononuclear  cells 
(PBMCs), the number of cells secreting IFN-γ was related with 
the  serum  level  of  DHEA  sulfate  ester  (DHEAS)
8).  In  addition, 
patients  with  asthma
9, 10)  or  atopic  dermatitis
11),  another  Th2- 
associated  disease,  showed  significantly  lower  levels  of  serum 
DHEA compared with healthy controls. Moreover, Tabata et al.
11) 
showed  that  DHEA  significantly  reduced  IL-4  production  in 
PBMCs  from  patients  with  atopic  dermatitis.
T h e  p u r p o s e  o f  t h i s  s t u d y  w a s  t o  e x a m i n e  w h e t h e r  D H E A  
suppresses  Th2  cytokine  production  in  cultured  PBMCs  from 
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MATERIALS AND METHODS
Subjects 
Sixty-one  consecutive  suspected  asthmatic  or  non-asthmatic 
men  (age  range,  18～34  years)  were  recruited  from  Chonnam 
National University Hospital. Most of the patients with suspected 
asthma  were  young  men  who  required  a  medical  certificate  for 
asthma  before  they  could  be  exempted  from  obligatory  military 
service. Most non-asthmatic subjects were medical students and 
doctors.  Female  subjects  were  also  recruited,  but  only  18 
subjects responded (age range, 21～38 years). Participants were 
classified  according  to  gender  and  the  presence  of  airway 
hyperresponsiveness  (AHR),  based  on  their  responses  to  a 
methacholine bronchoprovocation test. All controller medications 
for asthma, including oral steroids, were withheld for more than 
1  week  before  enrollment.  The  Institutional  Review  Board  of 
C h o n n a m  N a t i o n a l  U n i v e r s i t y  H o s p i t a l  a p p r o v e d  t h i s  s t u d y .  A l l  
subjects  were  informed  of  the  experimental  procedures  and 
provided  written  informed  consent. 
Study  design
On the day of the study, a medical history was obtained and 
a  physical  examination  was  performed.  Allergy  skin-prick  tests, 
baseline spirometry, and a methacholine bronchoprovocation test 
to detect AHR were conducted, in addition to several laboratory 
analyses,  including complete  blood counts,  total IgE levels, and 
quantification of serum DHEAS and cortisol. A blood sample was 
drawn  for  PBMC  culture.  The  fresh  blood  was  immediately 
processed  to  isolate  PBMCs,  which  were  cultured  with  and 
without DHEA. The culture supernatant was assayed for Th1 and 
Th2  cytokines  via  an  enzyme-linked  immunosorbent  assay 
(ELISA). 
Asthma  tests 
Allergy skin-prick tests were carried out using the following 10 
common  aeroallergen  extracts  (Allergopharma,  Reinbek, 
Germany):  Dermatophagoides  farinae,  D.  pteronyssinus,  cock-
roach, cat, dog, Aspergillus fumigatus, hazel, birch, timothy, and 
ragweed. Histamine (1 mg/mL) and saline (0.9%) solutions were 
used  as  positive  and  negative  controls,  respectively.  Reactivity 
was graded on a scale of 0～4+ for each allergen, based on the 
ratio of the size of the allergen-induced wheal to the size of the 
histamine-induced wheal. The sum of all 10 grades was used as 
a n  o v e r a l l  “ a t o p y  s c o r e , ”  a n d  t h e  s u m  o f  t h e  s c o r e s  f o r  D. 
farinae  and  D.  pteronyssinus  was  designated  the  “house  dust 
mite  score.”  Total  serum  IgE  levels  were  measured  by 
nephelometry  (Behring  Diagnostics  GmbH,  Germany).
The  bronchial  challenge  tests  followed  a  standardized  tidal 
breathing  method  as  described  previously
12).  Aerosols  were 
generated  using  a  DeVilbiss  646  nebulizer  (DeVilbiss  Co., 
Somerset,  PA,  USA;  output,  0.13  mL/min),  and  airway 
responses to methacholine (Sigma, St. Louis, MO, USA) aerosols 
were  measured  using  a  spirometer  (Spiro  Analyzer  ST-250, 
Fukuda  Sangyo,  Tokyo,  Japan).  The  provocation  concentration 
of methacholine (PC20) that resulted in a 20% decrease in forced 
expiratory  volume  in  1 s  (FEV1)  was  calculated  by  linear 
interpolation  of  the  log  dose-response  curve.  AHR  was  defined 
as  methacholine  PC20 <  1 6  m g / m L .  A n  i n d e x  o f  b r o n c h i a l  
reactivity (BRindex) was calculated as log10 [10 + the maximal% 
fall  in  FEV1/log10 ( d o s e  i n  m g / d l  o f  t h e  s t i m u l u s  r e q u i r e d  t o  
produce maximal%  fall)]
13).
Hormone  and  cytokine  assay
Serum concentrations of DHEAS and cortisol were measured 
via  radioimmunoassay  using  commercially  available  kits 
(Diagnostic  Products  Corp.,  Los  Angeles,  CA,  USA).  Radioacti-
vity  was  quantified  using  a  gamma  counter  (Cobra  5010 
Q u a n t u m;  P a c k a r d  I n s t r u me n t  C o . ,  Me r i d e n ,  C T ,  U S A ) .
PBMCs were isolated by centrifugation over a Ficoll-Hypaque 
density gradient (Lymphoprep; Nycomed Pharma, Oslo, Norway). 
The  PBMCs  were  washed  five  times  and  re-  suspended  at  a 
concentration  of 1×10
6  cells/mL in  RPMI medium 1640 (Gibco 
BRL,  Paisley,  UK)  supplemented  with  10%  fetal  bovine  serum 
( F B S ;  G i b c o ,  G r a n d  I s l a n d ,  N Y ,  U S A )  a n d  1 %  p e n i c i l l i n /  
streptomycin/amphotericin B (BioWhittaker, Walkersville, MD, USA). 
The  PBMCs  were  stimulated  with  a  T-cell-specific  mitogen, 
concanavalin  A  (Con  A;  2.5  μg/mL;  Sigma),  after  pre-incubation 
with DHEA (10 µmole; Sigma) for 1 h at 37℃. Some PBMCs were 
also pre-incubated with 0.01～1 µmole DHEA. After 48 h of culture, 
cell  culture  supernatants  were  collected  and  stored  at  70℃  until 
analysis.  The  concentrations  of  IFN-γ,  IL-5,  and  IL-10  were 
m e a s u r e d  u s i n g  c o m m e r c i a l l y  a v a ilable  ELISA  kits  (Biosource, 
Camarillo, CA, USA). Assay sensitivities for IFN- γ, IL-5, and IL-10 
w e r e  4 ,  4 ,  a n d  1  p g / m L ,  r e s p e c t i v e l y .
Statistical  analysis
Data are presented as the mean±standard error of the mean 
(SEM). PC20  values and IgE, hormone, and cytokine levels were 
log-transformed  before  analysis.  The  intra-group  difference  in 
cytokine  levels  was  determined  using  the  Wilcoxon  signed  rank 
and  Friedman  tests.  The  Mann-Whitney  U  test  was  used  to 
detect  significant  differences  between  groups.  Associations 
between  variables  were  examined  using  Spearman’s  rank 
correlation  coefficient.  A  value  of  p<0.05  was  considered 
statistically  significant. 
RESULTS
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AHR  (-) AHR  (+)
  (n=40)  (n=21)
Age  (years) 23.8±0.5 20.2±0.4
‡
FEV1  (%  predicted) 93.4±1.8 87.7±3.4
Methacholine-PC20 ( m g / m L )
§ -0 . 5 7  
BRindex 1.09±0.01 1.43±0.02
‡ 
Blood  eosinophil  (%)  2.7±0.3 5.4±0.7
‡
Serum  total  IgE  (IU/mL)
§ 97 222
† 
Atopy  score 5.5±1.0 12.7±1.2
‡ 
House  dust  mite  score 3.1±0.6 6.8±0.5
‡ 
Serum  cortisol  (μg/dL)
§ 9.7 9.9 
Serum  DHEAS  (μg/dL)
§ 260 228 
Cortisol/DHEAS  ratio×10
2 4.1±0.3 4.8±0.5 
PBMC  IL-10  (pg/mL)
§ 131 59
†
PBMC  IL-5  (pg/mL)
§ 150 84 
PBMC  IFN-γ  (pg/mL)
§ 425 276 
IFN-γ/IL-5  ratio 3.0±0.3 3.6±0.4
AHR,  airway  hyperresponsiveness;  FEV1,  f o r c e d  e x p i r a t o r y  v o l u m e  i n  1  s ;  P C 20,  the  provocation  concentration  resulting  in  a  20% 
decrease  in  FEV1;  BRindex,  bronchial  responsiveness  index;  Atopy  score,  sum  of  all  grades  for  skin  test  reactivity  in  response  to  10 
c o m m o n  a e r o a l l e r g e n s ;  H o u s e  d u s t  m i t e  s c o r e ,  s u m  o f  g r a d e s  f o r  Dermatophagoides  farinae a n d  D.  pteronyssinus  reactivity;  DHEAS, 
dehydroepiandrosterone  sulfate;  IFN,  interferon;  IL,  interleukin;  PBMC,  peripheral  blood  mononuclear  cells;  §Geometric  mean  values; 
†p<0.05  and 
‡p<0.01  compared  with  negative  AHR.
Table  1.  Comparisons  of  subject  characteristics
Figure  1.  Dose-response  relationship  for  the  suppressive  effect  of  dehydroepiandrosterone  (DHEA)  on
cytokine production in cultured peripheral blood mononuclear cells (expressed as% of baseline value)
and  the  resulting  fold  increase  in  the  interferon  (IFN)-γ/interleukin  (IL)-5  ratio  in  subjects  with airway
hyperresponsiveness. 
cantly  higher  BRindices,  eosinophil  proportions,  total  IgE  levels, 
atopy scores, and house dust mite scores, but lower IL-10 levels 
compared  with  men  without  AHR  (Table  1).  In  subjects  with 
A H R ,  t h e  a d d i t i o n  o f  D H E A  t o  C o n  A - s t i m u l a t e d  P B M C s  
significantly suppressed the production of IL-10, IL-5, and IFN-γ 
in  a  dose-dependent  manner  (all  p<0.001)  and  tended  to 
increase  the  IFN-γ/IL-5  ratio  (p=0.087;  Figure  1).  In  subjects 
without AHR, DHEA also significantly suppressed the production 
of  IL-10,  IL-5,  and  IFN-γ  in  a  dose-dependent  manner  (all 
p<0.001)  but  did  not  affect  the  IFN-γ/IL-5  ratio. Inseon  S.  Choi,  et  al.  Effects  of  DHEA  on  Th2  responses  in  PBMCs 179
AHR  (-) AHR  (+)
  (n=40)   (n=21)
IL-10  (%) 15.7±2.1
* 13.4±4.7
*
IL-5  (%) 40.9±3.6
*  24.0±7.8
*‡
IFN-γ  (%) 54.5±5.1
* 29.7±7.0
*‡
ΔIFN-γ/IL-5  ratio 1.4±0.1
*    5.2±2.3
AHR,  airway  hyperresponsiveness; 
*p<0.01  compared  with 
baseline; 
‡p<0.01  compared  with  negative  AHR. 
Table  2.  The  suppressive  effect  of  10  μM  dehydroepiandrosterone  on
concanavalin A-stimulated cytokine production in cultured peripheral blood
mononuclear cells (expressed as % of baseline value) and the resulting 
fold  increase  in  the  interferon  (IFN)-γ/interleukin  (IL)-5  ratio 













Blood  eosinophil 0.053 -0.175 -0.114 0.103
Serum  total  IgE -0.343
* -0.237 -0.279
* 0.024
Atopy  score -0.193 -0.202 -0.095 0.161
House  dust  mite  score  -0.388
** -0.239 -0.152 0.149
Serum  cortisol -0.206 -0.084 -0.167 0.003
Serum  DHEAS -0.179 -0.080 -0.184 -0.353
*
Cortisol/DHEAS  ratio -0.037 -0.141 -0.018 0.259
BRindex,  bronchial  responsiveness  index;  Atopy  score,  sum  of  all  grades  for  skin  test  reactivity  in  response  to  10  common 
aeroallergens;  House  dust  mite  score,  sum  of  grades  for  Dermatophagoides  farinae a n d  D.  pteronyssinus  reactivity;  DHEAS, 
dehydroepiandrosterone  sulfate.  *p<0.05  and 
**p<0.01.
Table 3. Relationships among the suppressive effect of 10 μM dehydroepiandrosterone on cytokine production (expressed as % of baseline value),
the  resulting  fold  increase  in  the  interferon  (IFN)-γ/interleukin  (IL)-5  ratio,  and  subject  characteristics.
The observed  changes  in  cytokine levels  and the  IFN-γ/IL-5 
ratio from baseline after treatment with the highest dose (10 μ
M)  of  DHEA  were  significant  in  all  comparisons,  except  for 
changes in the IFN-γ/IL-5 ratio in men with AHR, which showed 
a trend toward increasing (p=0.088) (Table 2). The maximal dose 
of  DHEA  markedly  suppressed  IL-5  production  in  subjects  with 
AHR  (24.0±7.8%)  compared  with  those  without  AHR  (40.9± 
3.6%,  p<0.01).  The  suppression  of  IFN-γ  production  was  also 
significantly  greater  in  subjects  with  AHR  (29.7±7.0%)  than  in 
those without AHR (54.5±5.1%, p<0.01). Although the resulting 
increase in the IFN-γ/IL-5 ratio tended to be higher in subjects 
w i t h  A H R  c o m p a r e d  w i t h  t h o s e  w i t h o u t  A H R ,  t h e  d i f f e r e n c e  
between  these  groups  did  not  reach  statistical  significance 
(p=0.71). 
In  male  subjects,  significant  positive  relationships  were 
detected among IL-10, IL-5, and IFN-γ in terms of the degree 
of  DHEA  (10  μM)-induced  suppression  (expressed  as%  of 
baseline  value;  Table  3).  The  suppressive  effect  of  DHEA  on 
IL-10 was significantly related to AHR, serum total IgE level, and 
reactivity to house dust mites. In addition, both IL-5 and IFN-γ 
suppression  were  significantly  related  to  AHR,  IFN-γ 
suppression  was  significantly  related  to  serum  total  IgE 
concentrations, and the IFN-γ/IL-5 ratio was significantly related 
t o  s e r u m  D H E A S .  
Compared  with  women  without  AHR  (n=15),  men  without 
AHR  (n=40)  showed  a  significantly  higher  level  of  DHEAS 
(geometric mean: 153 vs. 260 μg/dL, ; p<0.01) but not cortisol 
( 8 . 2  v s .  9 . 7  μ g / d L ) ,  w h i c h  r e s u l t e d  i n  a  s i g n i f i c a n t l y  l o w e r  
cortisol/DHEAS  ratio  (6.1±0.9  vs.  4.1±0.3%,  p<0.05). 
Compared  with  female  subjects,  male  subjects  showed 
significantly  higher  eosinophil  proportions,  total  IgE  levels,  and 
atopy  scores,  but  lower  IL-10  levels  (199  vs.  131  pg/mL, 
p<0.01).  Similar  to  male  subjects,  female  subjects  with  AHR 
exhibited  trends  toward  cytokine  suppression  (IL-10: 
13.3±1.9%,  IL-5:  44.2±7.0%,  IFN-γ:  68.4±7.4%;  all  p<0.01) 
and a Th1 shift (ΔIFN-γ/IL-5 ratio: 2.5±0.7; p<0.01). However, 
we  were  unable  to  evaluate  the  effect  of  DHEA  on  cytokine 
p r o d u c t i o n  i n  f e m a l e  s u b j e c t s  w i t h  A H R  o w i n g  t o  t h e  s m a l l  
sample size (n=3), despite the similar trends in the suppression 
and  Th1  shift.
DISCUSSION
In  this  study,  DHEA  suppressed  the  production  of  IL-5  in 
cultured  PBMCs,  resulting  in  a  non-significant  increase  in  the 
IFN-γ/IL-5 ratio in subjects with AHR. It has been reported that 
DHEA suppresses allergic inflammatory airway responses
6, 7) and 
serum  concentrations  of  IgE  and  IL-6
14)  in  animal  models  of 
asthma,  and  that  DHEA  reduces  IL-4  production  in  cultured 
PBMCs  from  patients  with  atopic  dermatitis
11).  The  mechanism 
by  which  DHEA  suppresses  allergic  responses  is  thought  to 
involve  a  shift  in  the  Th1/Th2  balance  toward  Th1.  Our  results The  Korean  Journal  of  Internal  Medicine:  Vol.  23,  No.  4,  December  2008 180
support  this  hypothesis.
The  Th1  cytokine  IFN-γ  inhibits  Th2  cells
15) a n d  p l a y s  a n  
important  role  in  regulating  the  allergic  airway  reaction
16, 17). 
However, in contrast to some reports that DHEA increases IFN-
γ  production
5, 18),  we  found  that  DHEA  suppressed  IFN-γ 
production  in  a  dose-dependent  manner.  Similar  results  have 
been reported by Yu et al.
6, 7) and Araneo et al.
19). Therefore, our 
results suggest that a mechanism mediated by some other factor 
(i.e.,  not  IFN-γ)  mediates  the  DHEA-associated  suppression  of 
the  Th2  cytokine  IL-5.  Unfortunately,  we  did  not  quantify  the 
number of PBMCs in our study; however, it has been reported that 
DHEA  suppresses  the  proliferation  of  Con  A-stimulated  spleno-
cytes  in  mice
20).  In  addition,  DHEA  antagonizes  glucocorticoid- 
induced deviation of the immune response toward a Th2 cytokine 
profile,  probably  through  the  peroxisome  proliferator-  activated 
receptor α
21). Alternatively, DHEA may down-regulate both IFN-
γ and IL-5 production while maintaining a Th1 bias, which would 
suggest  that  the  balance  between  Th1  and  Th2  is  more 
important  than  the  actual  level  of  Th1  cytokines  in  determining 
the  influence  of  DHEA  on  asthma. 
IL-10  drives  the  generation  of  T  regulatory  1  cells
22),  which 
produce  IL-10,  and  in  turn,  IL-10  inhibits  both  Th1  and  Th2 
cytokine  production
23).  Asthma  is  associated  with  diminished 
IL-10 expression in the allergic airway
24), which is consistent with 
our  result  showing  that  the  baseline  IL-10  levels  were  lower  in 
male  subjects  with  AHR  than  in  those  without  AHR.  However, 
the  IL-10  concentration  in  PBMCs  was  significantly  reduced  by 
treatment  with  DHEA,  and  we  observed  a  significant  positive 
correlation between the changes in IL-10 and IL-5 levels. Yu et 
al.
6)  also  showed  that  DHEA  decreased  the  production  of  both 
IL-5  and  IL-10.  Although  it  has  been  demonstrated  that  DHEA 
induces  IL-10  production  in  spleen  cells
25),  the  decreased 
production  of  IL-10  may  be  the  result  of  suppressed  cell 
proliferation
20)  and  other  mechanisms. 
Relatively  more  severe  atopy  or  asthma  was  associated  with 
a  greater  degree  of  DHEA-induced  cytokine  suppression  in  this 
study.  Because  inflammatory/immune  cells  are  activated  during 
active  allergic  disease  processes  and  because  DHEA  up- 
regulates  DHEA  receptor  activity  in  activated  human  T  lympho-
cytes
26),  DHEA  would  likely  be  more  effective  in  suppressing 
inflammatory/immune  responses  during  active  allergic  diseases. 
As  DHEA  is  an  adrenal  androgen,  it  is  expected  that  the 
serum  DHEAS  level  and  cortisol/DHEAS  ratio  would  differ 
significantly  between  male  and  female  subjects  without  AHR.  It 
has been reported that IFN-γ production in PBMCs is positively 
correlated  with  the  plasma  DHEA  level  and  inversely  correlated 
with  the  cortisol/DHEA  ratio
27).  Therefore,  the  effects  of  DHEA 
treatment  are  likely  influenced  by  gender.  In  the  present  study, 
exogenous  DHEA  increased  the  IFN-γ/IL-5  ratio  in  an  inverse 
relationship  with  the  serum  DHEAS  level,  even  though  cytokine 
suppression and increased IFN-γ/IL-5 ratios tended to occur in 
both  genders.  These  results  are  consistent  with  our  previous 
study  suggesting  that  in  men,  the  higher  background  levels  of 
D H E A  a n d  o t h e r  a n d r o g e n s  a s s o c i a t e d  w i t h  t h e  T h 1  b i a s  m a y  
r e s u l t  i n  a n  a d a p t i o n  t o  D H E A ,  a n d  t h u s  g r e a t e r  T h 1 - i n d u c i n g  
power may be necessary to overcome this adaptation in men
28). 
The  number  of  female  subjects  with  AHR  in  this  study  was 
too small to evaluate the effects of DHEA among AHR subjects 
and  between  AHR  and  non-AHR  subjects.  Thus,  further 
investigation  involving  a  much  larger  sample  size  is  required. 
Furthermore,  because  serum  concentrations  of  DHEAS  and 
cortisol are influenced by many factors, precise measurement is 
required  in  this  regard. 
Collectively,  our  study  demonstrated  that  DHEA  decreased 
both IL-5 and IFN-γ production in cultured PBMCs and skewed 
the  Th1/Th2  balance  toward  Th1.  In  addition,  the  suppressive 
effect  of  DHEA  on  cytokine  production  was  related  to  the 
severity of AHR or atopy. Therefore, DHEA supplementation may 
have  therapeutic  benefits  for  asthmatics.
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